GRK2 and myeloid sarcoma: Interestingly, a previous study reported reduced GRK2 protein levels in peripheral blood mononuclear cells (PBMCs) isolated from people with relapsing–remitting and secondary progressive MS suggesting an altered regulation of S1PR1 internalization31.